Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Dendrimers as nonviral vectors in dendritic cell-based immunotherapies against human immunodeficiency virus: steps toward their clinical evaluation.

Vacas-Córdoba E, Climent N, De La Mata FJ, Plana M, Gómez R, Pion M, García F, Muñoz-Fernández MÁ.

Nanomedicine (Lond). 2014 Dec;9(17):2683-702. doi: 10.2217/nnm.14.172.

PMID:
25529571
2.

Nanotech-derived topical microbicides for HIV prevention: the road to clinical development.

Sánchez-Rodríguez J, Vacas-Córdoba E, Gómez R, De La Mata FJ, Muñoz-Fernández MÁ.

Antiviral Res. 2015 Jan;113:33-48. doi: 10.1016/j.antiviral.2014.10.014. Epub 2014 Nov 7.

PMID:
25446339
3.

Enhanced activity of carbosilane dendrimers against HIV when combined with reverse transcriptase inhibitor drugs: searching for more potent microbicides.

Vacas-Córdoba E, Galán M, de la Mata FJ, Gómez R, Pion M, Muñoz-Fernández MÁ.

Int J Nanomedicine. 2014 Jul 29;9:3591-600. doi: 10.2147/IJN.S62673. eCollection 2014.

4.

Development of sulphated and naphthylsulphonated carbosilane dendrimers as topical microbicides to prevent HIV-1 sexual transmission.

Vacas Córdoba E, Arnaiz E, Relloso M, Sánchez-Torres C, García F, Pérez-Álvarez L, Gómez R, de la Mata FJ, Pion M, Muñoz-Fernández MÁ.

AIDS. 2013 May 15;27(8):1219-29. doi: 10.1097/QAD.0b013e32835f2b7a.

PMID:
23925376
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk